Identifying the association between polymorphisms in the GZMB and IFIH1 genes and psoriasis in Egyptians

References

• Yang, K.; Oak, A. S.; Elewski, B. E. Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review. Am. J. Clin Dermatol. 2020, 22(2), 1–20. DOI: 10.1007/s40257-020-00578-0
   Web of Science ®Google Scholar
• Zhang, X.; Gu, H.; Xie, S.; Su, Y. Periodontitis in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Oral Dis. 2022, 28(1), 33–43. DOI: 10.1111/odi.13617
   PubMed Web of Science ®Google Scholar
• Krueger, J. G.; McInnes, I. B.; Blauvelt, A. Tyrosine Kinase 2 and Janus Kinase‒Signal Transducer and Activator of Transcription Signaling and Inhibition in Plaque Psoriasis. J. Amer. Acad. Derm. 2022, 86(1), 148–157. DOI: 10.1016/j.jaad.2021.06.869
   PubMed Web of Science ®Google Scholar
• Duffin, K. C.; Mason, M. A.; Gordon, K.; Harrison, R. W.; Crabtree, M. M.; Guana, A.; Germino, R.; Lebwohl, M. Characterization of Patients with Psoriasis in Challenging-To-Treat Body Areas in the Corrona Psoriasis Registry. Dermatology. 2021, 237(1), 46–55. DOI: 10.1159/000504841
   PubMed Web of Science ®Google Scholar
• Seyedmirzaei, H.; Rezaei, N. Cytokine Alterations in Psoriasis: An Updated Review. Expert Rev. Clin. Immunol. 2022, 17(12), 1323–1335. DOI: 10.1080/1744666X.2022.2011720
   Web of Science ®Google Scholar
• Jeong, K. H.; Kim, S. K.; Seo, J. K.; Shin, M. K.; Lee, M. H. Association of GZMB Polymorphisms and Susceptibility to Non-Segmental Vitiligo in a Korean Population. Sci. Rep. 2021, 11(1), 1–7. DOI: 10.1038/s41598-020-79705-0
   PubMedGoogle Scholar
• Rice, G. I.; Park, S.; Gavazzi, F.; Adang, L. A.; Ayuk, L. A.; Van Eyck, L.; Seabra, L.; Barrea, C.; Battini, R.; Belot, A., et al. Genetic and Phenotypic Spectrum Associated with IFIH1 Gain of Function. Hum. Mutat. 2020, 41(4), 837–849. DOI: 10.1002/humu.23975
   PubMed Web of Science ®Google Scholar
• Junior, A. G. D.; Sampaio, N. G.; Rehwinkel, J. A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation. Trends Microbiol. 2019, 27(1), 75–85. DOI: 10.1016/j.tim.2018.08.007
   PubMed Web of Science ®Google Scholar
• Newby, B. N.; Brusko, T. M.; Zou, B.; Atkinson, M. A.; Clare-Salzler, M.; Mathews, C. E. Type 1 Interferons Potentiate Human CD8+ T-Cell Cytotoxicity Through a STAT4- and Granzyme B-Dependent Pathway. Diabetes. 2017, 66(12), 3061–3071. Epub 2017 Sep 6. PMID: 28877912; PMCID: PMC5697952. DOI: 10.2337/db17-0106
   PubMed Web of Science ®Google Scholar
• Louden, B. A.; Pearce, D. J.; Lang, W.; Feldman, S. R. A Simplified Psoriasis Area Severity Index (SPASI) for Rating Psoriasis Severity in Clinic Patients. Dermatol. Online J. 2004, 15(10(2)), 7. PMID: 15530297. DOI: 10.5070/D318W9J736
   Google Scholar
• Keys, A.; Fidanza, F.; Karvonen, M. J.; Kimura, N.; Taylor, H. L. Indices of Relative Weight and Obesity. J.Chron. Dis. 1972, 25(6), 329–343. DOI: 10.1016/0021-9681(72)90027-6
   PubMedGoogle Scholar
• Zámocký, M.; Koller, F. Understanding the Structure and Function of Catalases: Clues from Molecular Evolution and in vitro Mutagenesis. Prog. Biophys. Mol. Biol. 1999, 72(1), 19–66. DOI: 10.1016/S0079-6107(98)00058-3
   PubMed Web of Science ®Google Scholar
• Mattson, J. P.; Sun, J.; Murray, D. M.; Poole, D. C. Lipid Peroxidation in the Skeletal Muscle of Hamsters with Emphysema. Pathophysiology. 2002, 8(3), 215–221. DOI: 10.1016/S0928-4680(02)00011-1
   PubMedGoogle Scholar
• Potestio, L.; Ruggiero, A.; Fabbrocini, G.; Martora, F.; Megna, M. Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis: Targets Ther. 2023, 13, 19–26. DOI: 10.2147/PTT.S407647
   PubMed Web of Science ®Google Scholar
• Kiełbowski, K.; Bakinowska, E.; Ostrowski, P.; Pala, B.; Gromowska, E.; Gurazda, K.; Dec, P.; Modrzejewski, A.; Pawlik, A. The Role of Adipokines in the Pathogenesis of Psoriasis. Int. J. Mol. Sci. 2023, 24(7), 6390. PMID: 37047363; PMCID: PMC10094354. DOI: 10.3390/ijms24076390
   PubMed Web of Science ®Google Scholar
• Nestle, F. O.; Kaplan, D. H.; Barker, J. Psoriasis. N. Engl. J. Med. 2009, 361, 496–509. DOI: 10.1056/NEJMra0804595
   PubMed Web of Science ®Google Scholar
• Srivastava, A. K.; Chand Yadav, T.; Khera, H. K.; Mishra, P.; Raghuwanshi, N.; Pruthi, V.; Prasad, R. Insights into Interplay of Immunopathophysiological Events and Molecular Mechanistic Cascades in Psoriasis and its Associated Comorbidities. JAutoimmun. 2021, 118, 102614. DOI: 10.1016/j.jaut.2021.102614
   PubMed Web of Science ®Google Scholar
• Fan, X.; Yang, S.; Huang, W.; Wang, Z.-M.; Sun, L.-D.; Liang, Y.-H.; Gao, M.; Ren, Y. Q.; Zhang, K. Y.; Du, W. H.; et al. Fine Mapping of the Psoriasis Susceptibility Locus PSORS1 Supports HLA-C as the Susceptibility Gene in the Han Chinese Population. PLOS Genet. 2008, 4(3), e1000038. DOI: 10.1371/journal.pgen.1000038
   PubMed Web of Science ®Google Scholar
• Mahil, S. K.; Capon, F.; Ba Rker, J. N. Genetics of Psoriasis. Dermatol. Clin. 2015, 33, 1–11. DOI: 10.1016/j.det.2014.09.001
   PubMed Web of Science ®Google Scholar
• Li, Y.; Begovich, A. B. Unraveling the Genetics of Complex Diseases: Susceptibility Genes for Rheumatoid Arthritis and Psoriasis. Semin. Immunol. 2009, 21(6), 318–327. PubMed: 19446472. DOI: 10.1016/j.smim.2009.04.002
   PubMed Web of Science ®Google Scholar
• Besch, R.; Poeck, H.; Hohenauer, T.; Senft, D.; Hacker, G.; Berking, C.; Hornung, V.; Endres, S.; Ruzicka, T.; Rothenfusser, S., et al., Proapoptotic Signaling Induced by RIG-I and MDA-5 Results in Type I Interferon–Independent Apoptosis in Human Melanoma Cells. J. Clin. Invest. 2009, 119, 2399–2411. PubMed: 19620789. DOI: 10.1172/JCI37155
   PubMed Web of Science ®Google Scholar
• Kato, H.; Takeuchi, O.; Sato, S.; Yoneyama, M.; Yamamoto, M.; Matsui, K.; Uematsu, S.; Jung, A.; Kawai, T.; Ishii, K. J., et al. Differential Roles of MDA5 and RIG-I Helicases in the Recognition of RNA Viruses. Nature. 2006, 441(7089), 101–105. PubMed: 16625202. DOI:10.1038/nature04734
   PubMed Web of Science ®Google Scholar
• Fry, L.; Baker, B. S. Triggering Psoriasis: The Role of Infections and Medications. Clin. Dermatol. 2007, 25(6), 606–615. PubMed: 18021899. DOI: 10.1016/j.clindermatol.2007.08.015
   PubMed Web of Science ®Google Scholar
• Prens, E. P.; Kant, M.; van Dijk, G.; van der Wel, L. I.; Mourits, S.; van der Fits, L. IFN-α Enhances Poly-IC Responses in Human Keratinocytes by Inducing Expression of Cytosolic Innate RNA Receptors: Relevance for Psoriasis. J. Invest. Dermatol. 2008, 128(4), 932–938. PubMed: 17928888. DOI: 10.1038/sj.jid.5701087
   PubMed Web of Science ®Google Scholar
• Looney, B. M.; Xia, C. Q.; Concannon, P.; Ostrov, D. A.; Clare-Salzler, M. J. Effects of Type 1 Diabetes-Associated IFIH1 Polymorphisms on MDA5 Function and Expression. Curr. Diab. Rep. 2015, 15(11), 96. PMID: 26385483. DOI: 10.1007/s11892-015-0656-8
   PubMed Web of Science ®Google Scholar
• Wilkins, C.; Gale, M., Jr. Recognition of Viruses by Cytoplasmic Sensors. Curr. Opin. Immunol. 2010, 22(1), 41–47. DOI: 10.1016/j.coi.2009.12.003
   PubMed Web of Science ®Google Scholar
• Kang, D.; Gopalkrishnan, R. V.; Wu, Q.; Jankowsky, E.; Pyle, A. M.; Fisher, P. B. Mda-5: An Interferon-Inducible Putative RNA Helicase with Double-Stranded RNA-Dependent ATPase Activity and Melanoma Growth-Suppressive Properties. Proc. Natl. Acad. Sci. USA. 2002, 99(2), 637–642. DOI: 10.1073/pnas.022637199
   PubMed Web of Science ®Google Scholar
• Li, X.; Lu, C.; Stewart, M.; Xu, H.; Strong, P. K.; Igumenova, T.; Li, P. Structural Basis of Double-Stranded RNA Recognition by the RIG-I Like Receptor MDA5. Arch. Biochem. Biophys. 2009, 488(1), 23–33. DOI: 10.1016/j.abb.2009.06.008
   PubMed Web of Science ®Google Scholar
• Shigemoto, T.; Kageyama, M.; Hirai, R.; Zheng, J.; Yoneyama, M.; Fujita, T. Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5: Implications for Resistance to Type I Diabetes. J. Biol. Chem. 2009, 284(20), 13348–13354. DOI: 10.1074/jbc.M809449200
   PubMed Web of Science ®Google Scholar
• Phan, L.; Jin, Y.; Zhang, H.; Qiang, W.; Shekhtman, E.; Shao, D.; Revoe, D.; Villamarin, R.; Ivanchenko, E.; Kimura, M.; et al. (2020) ALFA: Allele Frequency Aggregator. National Center for Biotechnology Information, U.S. National Library of Medicine. www.ncbi.nlm.nih.gov/snp/docs/gsr/alfa/ (accessed on Dec 4, 2022).
   Google Scholar
• Liu, S.; Wang, H.; Jin, Y.; Podolsky, R.; Reddy, M. V.; Pedersen, J.; Bode, B.; Reed, J.; Steed, D.; Anderson, S.; et al. IFIH1 Polymorphisms Are Significantly Associated with Type 1 Diabetes and IFIH1gene Expression in Peripheral Blood Mononuclear Cells. Hum. Mol. Genet. 2009, 18(2), 358–365. DOI: 10.1093/hmg/ddn342
   PubMed Web of Science ®Google Scholar
• Zervou, M. I.; Andreou, A. C.; Eliopoulos, E. E.; Goulielmos, G. N. Functional Significance of the Rare rs35667974 IFIH1 Gene Polymorphism, Associated with Multiple Autoimmune Diseases, Using a Structural Biological Approach. Autoimmunity. 2022, 55(7), 455–461. Epub 2022 Aug 2. PMID: 35918839. DOI: 10.1080/08916934.2022.2103799
   PubMed Web of Science ®Google Scholar
• Nejentsev, S.; Walker, N.; Riches, D.; Egholm, M.; Todd, J. A. Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes. Science. 2009, 324(5925), 387–389. PubMed: 19264985. DOI: 10.1126/science.1167728
   PubMed Web of Science ®Google Scholar
• Andreou, A.; Papakyriakou, A.; Zervou, M. I.; Goulielmos, G. N.; Eliopoulos, E. E. Is the Association of the Rare rs35667974 IFIH1 Gene Polymorphism with Autoimmune Diseases a Case of RNA Epigenetics? J. Mol. Evol. 2023, 91(2), 204–213. Epub 2023 Jan 18. PMID: 36651965; PMCID: PMC10082101. DOI: 10.1007/s00239-022-10090-0
   PubMed Web of Science ®Google Scholar
• Dahl, C. A.; Bach, F. H.; Chan, W.; Huebner, K.; Russo, G.; Croce, C. M.; Herfurth, T.; Cairns, J. S. Isolation of a cDNA Clone Encoding a Novel Form of Granzyme B from Human NK Cells and Mapping to Chromosome 14. Hum. Genet. Apr, 1990, 84(5), 465–470. PMID: 2323780. DOI:10.1007/BF00195821
   PubMed Web of Science ®Google Scholar
• Chowdhury, D.; Lieberman, J. Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death. Annu. Rev. Immunol. 2008, 26, 389–420. DOI: 10.1146/annurev.immunol.26.021607.090404
   PubMed Web of Science ®Google Scholar
• Espinoza, L. J.; Takami, A.; Nakata, K.; Yamada, K.; Onizuka, M.; Kawase, T.; Sao, H.; Akiyama, H.; Miyamura, K.; Okamoto, S., et al. Genetic Variants of Human Granzyme B Predict Transplant Outcomes After HLA Matched Unrelated Bone Marrow Transplantation for Myeloid Malignancies. PLoS One. 2011, 6(8), e23827. Epub 2011 Aug 23. PMID: 21886827; PMCID: PMC3160316. DOI: 10.1371/journal.pone.0023827
   PubMed Web of Science ®Google Scholar
• Kim, S.; Misra, A. SNP Genotyping: Technologies and Biomedical Applications. Annu. Rev. Biomed. Eng. 2007, 9, 289–320. DOI: 10.1146/annurev.bioeng.9.060906.152037
   PubMed Web of Science ®Google Scholar
• Wen, X.; Du, H.; Hao, X.; Wang, J.; Guo, Y. Expression of the GZMB Gene Polymorphism, SNP rs8192917, in 990 Han Chinese Patients with Postoperative Keloids. Med. Sci. Monit. 2022, 28, e936963. PMID: 35733327; PMCID: PMC9239282. DOI: 10.12659/MSM.936963
   PubMed Web of Science ®Google Scholar
• Oboshi, W.; Watanabe, T.; Hayashi, K.; Nakamura, T.; Yukimasa, N. QPY/RAH Haplotypes of the GZMB Gene Are Associated with Natural Killer Cell Cytotoxicity. Immunogenetics. 2017 Jan, 70(1), 29–36. Epub; 26. PMID: 28653095. DOI: 10.1007/s00251-017-1014-6
   PubMed Web of Science ®Google Scholar
• McIlroy, D.; Cartron, P. F.; Tuffery, P.; Dudoit, Y.; Samri, A.; Autran, B.; Vallette, F. M.; Debré, P.; Theodorou, I. A Triple-Mutated Allele of Granzyme B Incapable of Inducing Apoptosis. Proc. Natl. Acad. Sci. 2003, 100(5), 2562–2567. DOI: 10.1073/pnas.0437935100
   PubMed Web of Science ®Google Scholar
• Jeong, K. H.; Kim, S. K.; Seo, J. K.; Shin, M. K.; Lee, M. H. Association of Gzmb Polymorphisms and Susceptibility to Non-Segmental Vitiligo in a Korean Population. Sci. Rep. 2021, 11(1), 397. DOI: 10.1038/s41598-020-79705-0
   PubMedGoogle Scholar
• Xu, M.; Liu, Y.; Liu, Y.; Li, X.; Chen, G.; Dong, W.; Xiao, S. Genetic Polymorphisms of GZMB and Vitiligo: A Genetic Association Study Based on Chinese Han Population. Sci. Rep. 2018, 8(1), 13001. PMID: 30158536; PMCID: PMC6115438. DOI: 10.1038/s41598-018-31233-8
   PubMedGoogle Scholar
• Yentur, S. P.; Aydin, H. N.; Gurses, C.; Demirbilek, V.; Kuru, U.; Uysal, S.; Yapici, Z.; Baris, S.; Yilmaz, G.; Cokar, O.; et al. Granzyme B Gene Polymorphism Associated with Subacute Sclerosing Panencephalitis. Neuropediatrics. 2014, 45 (5), 309–313. DOI: 10.1055/s-0034-1378129
   PubMed Web of Science ®Google Scholar
• Asa’ad, F.; Fiore, M.; Alfieri, A.; Pigatto, P. D. M.; Franchi, C.; Berti, E.; Maiorana, C.; Damiani, G. Saliva as a Future Field in Psoriasis Research. Biomed Res. Int. 2018, 2018, 1–6. DOI: 10.1155/2018/7290913
   Web of Science ®Google Scholar
• Pietrucha, B.; Heropolitanska-Pliszka, E.; Maciejczyk, M.; Car, H.; Sawicka-Powierza, J.; Motkowski, R.; Karpinska, J.; Hryniewicka, M.; Zalewska, A.; Pac, M. et al. Comparison of Selected Parameters of Redox Homeostasis in Patients with Ataxia-Telangiectasia and Nijmegen Breakage Syndrome. Oxid. Med. Cell. Longev. 2017, 2017, 8. DOI: 10.1155/2017/6745840
   Web of Science ®Google Scholar
• Maciejczyk, M.; Szulimowska, J.; Skutnik, A.; Taranta-Janusz, K.; Wasilewska, A.; Wiśniewska, N.; Zalewska, A. Salivary Biomarkers of Oxidative Stress in Children with Chronic Kidney Disease. J. Clin. Med. 2018, 7(8), 209. PMID: 30103431; PMCID: PMC6111793. DOI: 10.3390/jcm7080209
   PubMed Web of Science ®Google Scholar
• Lin, X.; Huang, T. Oxidative Stress in Psoriasis and Potential Therapeutic Use of Antioxidants. Free Radic. Res. 2016, 50(6), 585–595. Epub 2016 Apr 21. PMID: 27098416. DOI: 10.3109/10715762.2016.1162301
   PubMed Web of Science ®Google Scholar
• Drewa, G.; Krzyzyńska-Malinowska, E.; Woźniak, A.; Protas-Drozd, F.; Mila-Kierzenkowska, C.; Rozwodowska, M.; Kowaliszyn, B.; Czajkowski, R. Activity of Superoxide Dismutase and Catalase and the Level of Lipid Peroxidation Products Reactive with TBA in Patients with Psoriasis. Med. Sci. Monit. 2002, 8(8), BR338–43. PMID: 12165738.
   PubMedGoogle Scholar
• Barygina, V. V.; Becatti, M.; Soldi, G.; Prignano, F.; Lotti, T.; Nassi, P.; Wright, D.; Taddei, N.; Fiorillo, C. Altered Redox Status in the Blood of Psoriatic Patients: Involvement of NADPH Oxidase and Role of Anti-TNF-α Therapy. Redox Rep. 2013, 18(3), 100–106. Epub 2013 Apr 19. PMID: 23601139; PMCID: PMC6837649. DOI: 10.1179/1351000213Y.0000000045
   PubMed Web of Science ®Google Scholar